Immediate Impact
15 standout
Citing Papers
Inflammation mechanism and research progress of COPD
2024 Standout
Biologics, theranostics, and personalized medicine in drug delivery systems
2024 Standout
Works of Luis Wehbe being referenced
Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial
2018
INSTEAD: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Luis Wehbe | 138 | 118 | 5 | 8 | 6 | 156 | |
| Giovita Piccillo | 106 | 203 | 10 | 4 | 9 | 247 | |
| A Capristo | 150 | 190 | 1 | 3 | 10 | 237 | |
| Nils E. Billo | 78 | 109 | 6 | 3 | 6 | 173 | |
| Claus Keller | 124 | 65 | 3 | 13 | 7 | 135 | |
| Clarisse Gautier | 47 | 66 | 7 | 1 | 5 | 118 | |
| Kirthi Gunasekera | 66 | 72 | 3 | 6 | 94 | ||
| Philip Chetcuti | 170 | 94 | 12 | 7 | 176 | ||
| Dana Wallace | 112 | 133 | 4 | 6 | 146 | ||
| Burr Ml | 29 | 72 | 13 | 3 | 5 | 126 | |
| Laurence Ruane | 145 | 142 | 2 | 10 | 177 |
All Works
Loading papers...